The Pharma Letter7h
EMA/CHMP recommends approval for six biosimilars
The European Medicines Agency’s (EMA) human medicines committee (CHMP) adopted positive opinions for six biosimilar medicines ...
Pharmabiz7h
Vir Biotech gets US FDA breakthrough therapy designation & EMA PRIME designation for tobevibart, elebsiran to treat chronic hepatitis delta
announced that tobevibart and elebsiran have received US Food and Drug Administration breakthrough therapy designation and European Medicines Agency (EMA) Priority Medicines (PRIME) designation for ...
Aurobindo Pharma arm’s biosimilar gets EMA panel nod
Aurobindo Pharma's CuraTeQ Biologics receives positive opinion for Zefylti biosimilar from CHMP for EMA marketing authorization.
EU drugs regulator backs Mounjaro's sleep apnea use without fresh approval for Lilly
The European Medicines Agency has allowed Eli Lilly to update the product label of its weight-loss drug Mounjaro to show it ...
Roche Vabysmo PFS approved in EU for three retinal conditions
Roche (RHHBY) announced that the European Medicines Agency, EMA, has approved Vabysmo 6.0 mg single-dose prefilled syringe, ...
Geron announces positive CHMP opinion for Rytelo
Geron (GERN) announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a ...
Are expensive drugs worth it? Rolling out new medicines may be too costly to other patients' health
A new study has found that the approval of new drugs in England has come at a heavy cost to the health of many others due to ...
Daily14h
ELi Lilly Omvoh recommended by CHMP for approval in EU for adults with moderately to severely active Crohn's disease
Indianapolis: Eli Lilly and Company has announced that the European Medicines Agency's (EMA) Committee for Medicinal Products ...
Daily14h
Aurobindo Pharma arm gets positive opinion from EMA Committee for Zefylti for neutropenia treatment
Hyderabad: CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma Limited, has announced that the ...
ndtvprofit15h
New Study Links Paracetamol To Digestive, Heart, And Kidney Side Effects In Older Adults
Taking the drug may also increase the risk of chronic kidney disease by 19%, heart failure by 9% and hypertension by 7%.
Business Wire16h
Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis
Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis ...
Pharmabiz17h
EMA approves Roche’s Vabysmo prefilled syringe for three retinal conditions that can cause blindness
EMA approves Roche’s Vabysmo prefilled syringe for three retinal conditions that can cause blindness: Basel Saturday, December 14, 2024, 10:00 Hrs [IST] Roche announced that the ...